decisionhealth Newsletters, Coder Pink Sheets - 2008 Issue 3 (March)
Restore former HCPCS codes for albuterol/levalbuterol
Subscribe or sign in to view the full article.
Article Overview
This article covers a Medicare HCPCS quarterly update affecting coding for respiratory inhalation drugs used in office and DME-related settings. It is aimed at primary care coders and billing staff who need to understand how CMS code-set changes may differ from private payer requirements, and it also notes related additions to the HCPCS code set.
Why This Topic Matters
The article helps readers recognize that Medicare may temporarily treat certain HCPCS entries differently from private payers and that quarterly updates can affect drug supply reporting in everyday practice. It is relevant for maintaining current billing workflows, payer-specific code tracking, and awareness of broader HCPCS changes.
What You Will Learn
- How a Medicare HCPCS quarterly update can affect respiratory drug coding
- Why payer-specific requirements may differ from Medicare guidance
- What types of HCPCS code-set changes may appear in the same update
- How office billing staff can track payer-specific code requirements
Who Should Read This
- Primary care coders
- Medical billers
- Revenue cycle staff
- Practice managers
- Healthcare administrators
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com